课题基金 / 基金详情

Studies on the development of diagnosis for infectious diseases among laboratory rodents

Studies on the development of diagnosis for infectious diseases among laboratory rodents
实验啮齿类动物传染病诊断研究进展
批准号:
11558096
负责人:
ARIKAWA Jiro
金额:
$8.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

ARIKAWA Jiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. Nucleocapsid (N) proteins of Hantaan, Seoul and Dobrava viruses were expressed by E. coli and baculovirus systems. The recombinant proteins by both systems produced enough amount of recombinant proteins and retained the anti genicity similar to those of authentic viruses. They are considered to be a ble to apply for ELISA antigen.2. The truncated N proteins which lacked 50 amino acids at N-terminal reduced the cross reactivity to antibody to heterologous serotypes. Therefore, the truncated antigens were applied as serotyping antigen.The ELISA with the truncated antigen able to serotype of patient and rodent sera from China and Far Eastern part of Russia as determined by ordinary neutralization test.3. Mouse hepatitis virus N protein gene was expressed by yeast system of which maximum expression was observed at 72 hours after culture. However, the antigenicity was too low to apply for ELISA antigen.4. cDNA of N protein of lymphocytic choriomeningitis (LCM) virus were cloned from Japanese isolate (strain OQ28) and prototype strain (strain WE). The cDNAs of full length, C-terminal region and central region were independently transfected to COS cells. Although they could express recombinant proteins, amount of antigen expressed was too small to apply to ELISA.5. Recombinant baculovirus expressing LCM virus N protein was provided from National Institute of Infectious Diseases Japan. Both the recombinant baculovirus infected SF-9 cells and Tm5 cells were found to be applicable for IFA antigen and ELISA antigen, respectively. A total of 9,840 mouse sera from 1,117 animal facility in Japan were tested for LCM virus antibody by IFA and ELISA. From these results, screening with ELISA followed by confirmation by IFA was recommended.
期刊论文(218)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kanwa, H. et al.: "Detection of hantaviral antibodies among patients with hepatitis of unknown etiology in Japan"Microbiol Immunol. 44(5). 357-362 (2000)
Kanwa, H. 等人:“日本病因不明的肝炎患者中汉坦病毒抗体的检测”Microbiol Immunol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
高倉彰: "動物検疫の現状「ICLASモニタリングセンターの微生物検査項目の見直し」"アニテックス. 12(4). 157-161 (2000)
Akira Takakura:“动物检疫现状‘ICLAS 监测中心微生物检测项目审查’Anitex 12(4) (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
73
    Studies on the immunochromatography for detecting antibody to major zoonoses and infectious diseases among laboratory rat and mouse.
    • 批准号:
      15K07717
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2015
    • 负责人:
      ARIKAWA Jiro
    • 依托单位:
    Studies on persistent hantavirus infection in rodents; throughoutanalysis of function of immune cells
    • 批准号:
      18300136
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.58万
    • 财政年份:
      2006
    • 负责人:
      ARIKAWA Jiro
    • 依托单位:
    Molecular biologic characterization of hatavirus pathogenicity
    • 批准号:
      11694228
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $3.97万
    • 财政年份:
      1999
    • 负责人:
      ARIKAWA Jiro
    • 依托单位:
    Studies on a mechanism of hantavirus persistent infection in central nervous system and immune system
    • 批准号:
      10306019
    • 项目类别:
      Grant-in-Aid for Scientific Research (A).
    • 资助金额:
      $22.78万
    • 财政年份:
      1998
    • 负责人:
      ARIKAWA Jiro
    • 依托单位:
    国内基金
    海外基金
    NLRC3-mTORC1轴介导的T细胞代谢重编程在HFRS急性肾损伤中的作用与机制研究
    渭河流域城市化对HFRS高位流行的驱动效应研究
    肾综合征出血热(HFRS)血小板减少免疫学新机制的研究
    DMP1在HFRS发病机制中的作用及机理研究
    • 批准号:
      81671545
    • 项目类别:
      面上项目
    • 资助金额:
      25.0万元
    • 批准年份:
      2016
    • 负责人:
      谢明
    • 依托单位: